Risk Factors of Post-ERCP Pancreatitis in Patients Receiving Rectal Indomethacin

CompletedOBSERVATIONAL

Enrollment

790

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions

Healthy

Trial Locations (3)

Department of gastroenterology,Chinese PLA 174 Hospital, Xiamen

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

Xijing Hospital of Digestive Diseases, Xi'an

All Listed Sponsors

lead

Air Force Military Medical University, China

OTHER

NCT02709421 - Risk Factors of Post-ERCP Pancreatitis in Patients Receiving Rectal Indomethacin | Biotech Hunter | Biotech Hunter